CMS released a broad-ranging proposed rule for the Medicare Advantage and Part D Programs on Thursday, November 16, 2017. The proposed rule addresses a broad and diverse range of MA and Part D regulatory requirements, affecting not only Medicare Advantage Organizations and Part D Sponsors, but also health care providers, pharmacies, pharmaceutical manufacturers and others.
CMS Releases Broad-Ranging Medicare Advantage and Part D Proposed Rule
Posted In Employee Benefits, Health and Welfare Plans
Tags: 21st Century Cures Act, 42 CFR § 423.505(b)(18), Any Willing Pharmacy provisions, AWP, Centers for Medicare & Medicaid Services (CMS), Comprehensive Addiction and Recovery Act of 2016, Medical Loss Ratios, Medicare Advantage, Medicare marketing guidelines, MLR, Part D AWP, Part D Programs, pharmacy rebates, plan sponsors, Proposed Rule, Section 1860D-4(b)(1)(A) of the Social Security Act, Star Ratings
Ankur J. GoelAnkur J. Goel represents health industry clients in significant compliance, False Claims Act, litigation and regulatory matters. Ankur works with a range of health industry clients. He represents health plans on issues arising under Medicare Advantage, Part D, and health insurance exchanges, as well as health care providers on a variety of complex enforcement, compliance, regulatory and litigation matters. Read Ankur Goel's full bio.
Kate McDonaldKate McDonald focuses her practice on transactional and regulatory counseling for clients in the health care industry, with particular focus on federal and state health care government programs and the intersection between health care payors and providers. Kate regularly advises health insurers, health maintenance organizations (HMOs), health care government contractors, health care providers and other clients on compliance with health care laws and regulations, particularly in connection with Medicare Advantage, Medicare Part D, Medicaid managed care, the Affordable Care Act, state insurance laws, and state licensure and professional practice regulations. Read Kate McDonald's full bio.
Lauren E. ParisiLauren E. Parisi focuses her practice on health advisory matters. Lauren has provided strategic counseling on federal and state legislation, regulations and sub-regulatory guidance related to the Affordable Care Act. She has experience tracking, analyzing and summarizing new regulatory developments related to federal health care reform. Lauren has also represented various clients in civil litigation, arbitration and government investigations. Read Lauren Parisi's full bio.
Related Posts
- Prescription Drug Data Reporting: What the “Good Faith Compliance” Extension Really Means for Self-Funded Group Health Plans
- Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure
- IRS Announces 2021 Employee Benefit Plan Limits
- Finally SECURE: Opportunities in the 2019 SECURE Act for Plan Sponsors
- IRS Announces 2020 Employee Benefit Plan Limits
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- GOP Calls Biden’s Medicare Plans a Tax Hike on Small Businesses
- The Bosses May Be Back in Charge (but Not as Much as They Think)
- Coverage of COVID-19 Vaccines and the End of the COVID-19 Emergency
- NLRB Attacks Non-Disparagement and Confidentiality Clauses in Employee Releases, Severance Agreements
- District Court Vacates Provisions of No Surprises Act Final Rule
